Home

широк Джанис Бери antonini cappellini giancarlo памет рай дивидент

gian carlo antonini cappellini - Oncologist - Ospedale Sandro Pertini - ASL  RM2 | LinkedIn
gian carlo antonini cappellini - Oncologist - Ospedale Sandro Pertini - ASL RM2 | LinkedIn

10+ "Giancarlo Antonini" profiles | LinkedIn
10+ "Giancarlo Antonini" profiles | LinkedIn

Intratumoral injection of IFN-alpha dendritic cells after dacarbazine  activates anti-tumor immunity: results from a phase I trial in advanced  melanoma | Journal of Translational Medicine | Full Text
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma | Journal of Translational Medicine | Full Text

Visual Clustering of Transcriptomic Data from Primary and Metastatic Tumors  – Dependencies and Novel Pitfalls
Visual Clustering of Transcriptomic Data from Primary and Metastatic Tumors – Dependencies and Novel Pitfalls

Identification of exosomal miRNA biomarkers for diagnosis of papillary  thyroid cancer by small RNA sequencing in: European Journal of  Endocrinology Volume 182 Issue 1 (2020)
Identification of exosomal miRNA biomarkers for diagnosis of papillary thyroid cancer by small RNA sequencing in: European Journal of Endocrinology Volume 182 Issue 1 (2020)

Identification of exosomal miRNA biomarkers for diagnosis of papillary  thyroid cancer by small RNA sequencing in: European Journal of  Endocrinology Volume 182 Issue 1 (2020)
Identification of exosomal miRNA biomarkers for diagnosis of papillary thyroid cancer by small RNA sequencing in: European Journal of Endocrinology Volume 182 Issue 1 (2020)

Gian CAPPELLINI | Istituto Dermopatico dell'Immacolata, Rome | IDI |  Oncologia
Gian CAPPELLINI | Istituto Dermopatico dell'Immacolata, Rome | IDI | Oncologia

gian carlo antonini cappellini - Oncologist - Ospedale Sandro Pertini - ASL  RM2 | LinkedIn
gian carlo antonini cappellini - Oncologist - Ospedale Sandro Pertini - ASL RM2 | LinkedIn

Intratumoral injection of IFN-alpha dendritic cells after dacarbazine  activates anti-tumor immunity: results from a phase I trial in advanced  melanoma – topic of research paper in Clinical medicine. Download scholarly  article PDF
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma – topic of research paper in Clinical medicine. Download scholarly article PDF

Investigating Serum and Tissue Expression Identified a Cytokine/Chemokine  Signature as a Highly Effective Melanoma Marker
Investigating Serum and Tissue Expression Identified a Cytokine/Chemokine Signature as a Highly Effective Melanoma Marker

PDF) Weekly administration of paclitaxel: theoretical and clinical basis |  Saik Urien - Academia.edu
PDF) Weekly administration of paclitaxel: theoretical and clinical basis | Saik Urien - Academia.edu

Intratumoral injection of IFN-alpha dendritic cells after dacarbazine  activates anti-tumor immunity: results from a phase I trial in advanced  melanoma | Journal of Translational Medicine | Full Text
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma | Journal of Translational Medicine | Full Text

TRIDENT analysis of melanoma vs control sera.
TRIDENT analysis of melanoma vs control sera.

Giancarlo Antonini (@gcarloantonini) / Twitter
Giancarlo Antonini (@gcarloantonini) / Twitter

Intratumoral injection of IFN-alpha dendritic cells after dacarbazine  activates anti-tumor immunity: results from a phase I trial in advanced  melanoma – topic of research paper in Clinical medicine. Download scholarly  article PDF
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma – topic of research paper in Clinical medicine. Download scholarly article PDF

7 perfiles de «Carlo Cappellini» | LinkedIn
7 perfiles de «Carlo Cappellini» | LinkedIn

Differential Denaturation of Serum Proteome Reveals a Significant Amount of  Hidden Information in Complex Mixtures of Proteins | PLOS ONE
Differential Denaturation of Serum Proteome Reveals a Significant Amount of Hidden Information in Complex Mixtures of Proteins | PLOS ONE

TRIDENT analysis of melanoma vs control sera.
TRIDENT analysis of melanoma vs control sera.

ioo;;-~~ ." - ,
ioo;;-~~ ." - ,

Gian CAPPELLINI | Istituto Dermopatico dell'Immacolata, Rome | IDI |  Oncologia
Gian CAPPELLINI | Istituto Dermopatico dell'Immacolata, Rome | IDI | Oncologia

Altro: Aree non comprese e Aree specifiche derivanti da progetti specifici
Altro: Aree non comprese e Aree specifiche derivanti da progetti specifici

gian carlo antonini cappellini - Oncologist - Ospedale Sandro Pertini - ASL  RM2 | LinkedIn
gian carlo antonini cappellini - Oncologist - Ospedale Sandro Pertini - ASL RM2 | LinkedIn

Genomic Classification of Cutaneous Melanoma - ScienceDirect
Genomic Classification of Cutaneous Melanoma - ScienceDirect

ioo;;-~~ ." - ,
ioo;;-~~ ." - ,

Investigating Serum and Tissue Expression Identified a Cytokine/Chemokine  Signature as a Highly Effective Melanoma Marker
Investigating Serum and Tissue Expression Identified a Cytokine/Chemokine Signature as a Highly Effective Melanoma Marker

Giancarlo CAPPELLINI | Istituto Dermopatico dell'Immacolata, Rome | IDI
Giancarlo CAPPELLINI | Istituto Dermopatico dell'Immacolata, Rome | IDI

PDF) Treatment-related side effects and quality of life in cancer patients
PDF) Treatment-related side effects and quality of life in cancer patients